US Stock MarketDetailed Quotes
FBLG FibroBiologics
- 12.180
- -0.140-1.14%
Close May 31 16:00 ET
- 12.180
- 0.0000.00%
Post 16:00 ET
398.52MMarket Cap-17677P/E (TTM)
12.733High12.018Low33.14KVolume12.500Open12.320Pre Close409.72KTurnover0.15%Turnover RatioLossP/E (Static)32.72MShares55.00052wk High-103.22P/B276.60MFloat Cap6.53052wk Low--Dividend TTM22.71MShs Float55.000Historical High--Div YieldTTM5.80%Amplitude6.530Historical Low12.364Avg Price1Lot Size
FibroBiologics Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | 52.32%3.45M | 98.99%8.89M | 90.18%2.48M | 52.95%2.05M | 2.09M | 2.27M | 183.08%4.47M | 1.3M | 1.34M | 1.58M |
| Selling and administrative expenses | 39.34%2.49M | 96.42%6.52M | 78.00%1.71M | 48.74%1.48M | --1.55M | --1.79M | 214.10%3.32M | --959K | --993K | --1.06M |
| -General and administrative expense | 39.34%2.49M | 96.42%6.52M | 78.00%1.71M | 48.74%1.48M | --1.55M | --1.79M | 214.10%3.32M | --959K | --993K | --1.06M |
| Research and development costs | 100.84%960K | 106.45%2.37M | 124.06%773K | 64.94%574K | --543K | --478K | 120.15%1.15M | --345K | --348K | --521K |
| Operating profit | -52.32%-3.45M | -98.99%-8.89M | -90.18%-2.48M | -52.95%-2.05M | -2.09M | -2.27M | -183.08%-4.47M | -1.3M | -1.34M | -1.58M |
| Net non-operating interest income expense | 125.93%35K | 77.52%-147K | 99.55%-1K | 0 | -11K | -135K | -16,250.00%-654K | -220K | -221K | -4K |
| Non-operating interest income | --39K | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Non-operating interest expense | -97.04%4K | -77.52%147K | -99.55%1K | --0 | --11K | --135K | 16,250.00%654K | --220K | --221K | --4K |
| Other net income (expense) | -33,533.33%-5.05M | -7.45M | -7.24M | -141K | -57K | -15K | ||||
| Other non- operating income (expenses) | -33,533.33%-5.05M | ---7.45M | ---7.24M | ---141K | ---57K | ---15K | ---- | ---- | ---- | ---- |
| Income before tax | -250.31%-8.46M | -221.91%-16.49M | -537.60%-9.72M | -40.33%-2.19M | -2.16M | -2.42M | -223.70%-5.12M | -1.52M | -1.56M | -1.58M |
| Income tax | ||||||||||
| Net income | -250.31%-8.46M | -221.91%-16.49M | -537.60%-9.72M | -40.33%-2.19M | -2.16M | -2.42M | -223.70%-5.12M | -1.52M | -1.56M | -1.58M |
| Net income continuous Operations | -250.31%-8.46M | -221.91%-16.49M | -537.60%-9.72M | -40.33%-2.19M | ---2.16M | ---2.42M | -223.70%-5.12M | ---1.52M | ---1.56M | ---1.58M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | -250.31%-8.46M | -221.91%-16.49M | -537.60%-9.72M | -40.33%-2.19M | -2.16M | -2.42M | -223.70%-5.12M | -1.52M | -1.56M | -1.58M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | 0 | 2.57M | 0 | 0 | 0 | 2.57M | 0 | 0 | 0 | |
| Net income attributable to common stockholders | -69.61%-8.46M | -272.15%-19.06M | -537.60%-9.72M | -40.33%-2.19M | -2.16M | -4.99M | -223.70%-5.12M | -1.52M | -1.56M | -1.58M |
| Basic earnings per share | -75.80%-0.27 | -272.15%-0.5868 | -537.60%-0.2992 | -40.33%-0.0675 | -0.0665 | -0.1536 | -223.71%-0.1577 | -0.0469 | -0.0481 | -0.0487 |
| Diluted earnings per share | -75.80%-0.27 | -272.15%-0.5868 | -537.60%-0.2992 | -40.33%-0.0675 | -0.0665 | -0.1536 | -223.71%-0.1577 | -0.0469 | -0.0481 | -0.0487 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
